Literature DB >> 11958532

A new hypothalamic polypeptide is a regulator of myelopoiesis.

Armen A Galoyan1, Vardan S Aprikyan.   

Abstract

The effect of hypothalamic proline-rich polypeptide (PRP) against Pseudomonas aeruginosa infection in BALB/c mice with leukopenia was investigated. Mice were treated with cyclophosphamide (CPA) and were then injected with PRP 24 h after CPA treatment. The lethal doses of P. aeruginosa were injected to mice when the number of peripheral blood leukocytes reached a nadir on day 5 after CPA administration. The administration of PRP significantly increased the survival of infected mice, and had a pronounced protective effect during the period of development of the infection. The number of bacteria in internal organs of PRP-treated mice was significantly lower than that in control mice. In PRP-treated mice, the neutrophil levels in peripheral blood started to increase 7 days after CPA administration and were consistently higher, and they were more mature than those in controls. Our results may indicate the ability of PRP to stimulate recovery of myelopoiesis and enhance mature neutrophil function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958532     DOI: 10.1023/a:1014959212651

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

Review 1.  Ikaros chromatin remodeling complexes in the control of differentiation of the hemo-lymphoid system.

Authors:  J Koipally; J Kim; B Jones; A Jackson; N Avitahl; S Winandy; M Trevisan; A Nichogiannopoulou; C Kelley; K Georgopoulos
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

Review 2.  Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on the bactericidal functions of neutrophils.

Authors:  D L Pitrak
Journal:  Curr Opin Hematol       Date:  1997-05       Impact factor: 3.284

Review 3.  Immune-neuro-endocrine interactions: facts and hypotheses.

Authors:  H O Besedovsky; A del Rey
Journal:  Endocr Rev       Date:  1996-02       Impact factor: 19.871

Review 4.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

Review 5.  Hematopoietic growth factors in the treatment of acute leukemia.

Authors:  E Estey
Journal:  Curr Opin Oncol       Date:  1998-01       Impact factor: 3.645

Review 6.  Lineage promiscuity in hemopoietic differentiation and leukemia.

Authors:  M F Greaves; L C Chan; A J Furley; S M Watt; H V Molgaard
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

Review 7.  Kinetics of granulocytopoiesis.

Authors:  E P Cronkite
Journal:  Clin Haematol       Date:  1979-06

Review 8.  Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways.

Authors:  D Pennica; W I Wood; K R Chien
Journal:  Cytokine Growth Factor Rev       Date:  1996-06       Impact factor: 7.638

9.  Differing contribution of polymorphonuclear cells and macrophages to protection of mice against Listeria monocytogenes and Pseudomonas aeruginosa.

Authors:  K Tatsukawa; M Mitsuyama; K Takeya; K Nomoto
Journal:  J Gen Microbiol       Date:  1979-11

Review 10.  A comparative review of colony-stimulating factors.

Authors:  J Nemunaitis
Journal:  Drugs       Date:  1997-11       Impact factor: 11.431

View more
  18 in total

1.  Effect of hypothalamic proline-rich-polypeptide on voltage-gated Ca2+ currents in retinal ganglion cells.

Authors:  Abram Akopian; Armen Galoyan
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

2.  Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Authors:  Armen A Galoyan; John S Sarkissian; Vergine A Chavushyan; Ruben M Sulkhanyan; Zaruhi E Avakyan; Zubeida A Avetisyan; Yuri Kh Grigorian; Davit O Abrahamyan
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

3.  Hypothalamic proline-rich polypeptide is an oxidative burst regulator.

Authors:  Tigran K Davtyan; Hayk M Manukyan; Gagik S Hakopyan; Nana R Mkrtchyan; Samvel A Avetisyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

4.  Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.

Authors:  Karina A Galoian; Thomas H Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2011-04-15

5.  Effect of hypothalamic proline-rich peptide (PRP-1) on neuronal and bone marrow cell apoptosis.

Authors:  Armen A Galoyan; Josef Krieglstein; Susanne Klumpp; Kristina E Danielian; Karine A Galoian; Wolfram Kremers; Kristina B Bezirganyan; Tigran K Davtyan
Journal:  Neurochem Res       Date:  2007-06-05       Impact factor: 3.996

6.  Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Authors:  Karina A Galoian; Toumy Guettouche; Biju Issac; Amir Qureshi; H T Temple
Journal:  Tumour Biol       Date:  2013-11-01

7.  The hypothalamic proline-rich polypeptide-1 (galarmin) and its analogue d-15 are the inhibitors of protein tyrosine kinase activity at cyclophosphamide-induced lymphocytopenia.

Authors:  Aida S Kirakosova; Silva S Abrahamyan; Narine V Tumasyan; Tigran K Davtyan; Anahit R Khachatryan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2011-08-14       Impact factor: 3.996

8.  Hypothalamic proline rich polypeptide regulates hematopoiesis.

Authors:  Kristina B Bezirganyan; Tigran K Davtyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2009-12-18       Impact factor: 3.996

9.  Proline-rich hypothalamic polypeptide has opposite effects on the proliferation of human normal bone marrow stromal cells and human giant-cell tumour stromal cells.

Authors:  R K Chailakhyan; Yu V Gerasimov; M R Chailakhyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2010-01-20       Impact factor: 3.996

10.  Proline-rich polypeptide-1 protects the cells in vitro from genotoxic effects of mitomycin C.

Authors:  R M Aroutiounian; G G Hovhannisyan; G H Gasparyan; K S Margaryan; D N Aroutiounian; N K Sarkissyan; A A Galoyan
Journal:  Neurochem Res       Date:  2009-12-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.